These findings suggest that PT-141 may act as an alternative ED treatment for subjects who do not respond to sildenafil, a potentiality that merits further research
133 The other two trials by Mulholland and colleagues (1990) and Parsons and colleagues (1993) reported that at three months, a significantly greater proportion of the PPS patients (28% and 32%, respectively) reported improvement compared to placebo patients (13% and 16%, respectively)
18.3%, respectively
The foundational chemistry was reported by Al-Obeidi, Castrucci, Hadley, and Hruby in J Med Chem 1989, describing the design rationale based on molecular dynamics modeling [2]
In research settings, it has been evaluated for its influence on growth hormone pulsatility, insulin-like growth factor-1 (IGF-1) modulation, and observed changes in visceral adipose tissue distribution within studied populations
Yapc M, Grsu BY, Da